Ethics: EGA Adopts Disclosure Requirements For The Generic, Biosimilar And Value Added Medicines Industry

15 January 2016

Brussels – Today, EGA members unanimously adopted disclosure rules for the […]

Generic and Biosimilar Medicines Essential for Italian Healthcare System

8 January 2016

Brussels – Generic and biosimilar medicines represent an essential opportunity to […]

Para Permitirse los Fármacos Innovadores Hay que Apoyar los Genéricos

22 November 2015

EFG: la EGA Califica de “Mala Noticia” la Eliminación de la Discriminación Positiva

17 November 2015

Les génériques rament pour accéder au marché

7 October 2015

A Comprehensive And Fair Solution To The Price Of Medicines

7 October 2015

After a long dry spell, the pharmaceutical research industry has […]

Launch of European Value Added medicines (EVA), a new EGA sector group, will deliver efficiency

12 June 2015

Brussels – The European Generic and Biosimilar medicines Association (EGA) announced […]

El Gobierno Español Todavía Tiene Margen para Promover la Competencia del Genérico

1 December 2014

Interview with Adrian van den Hoven in EV Healthcare

13 November 2014

No longer a niche market, generics are claiming new market […]

“Hay un enorme potencial para el mercado biosimilar si el marco es el adecuado”

17 March 2014

La patronal de genéricos anima a trasladar el foco desde […]